Bicara Therapeutics

Bicara Therapeutics

Biotechnology Research

Boston, Massachusetts 8,379 followers

Dual-action antibodies bringing together the precision of targeted therapies and the power of tumor modulators

About us

Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2020
Specialties
Immunotherapy, Targeted Oncology, and Drug Discovery

Locations

Employees at Bicara Therapeutics

Updates

Similar pages

Browse jobs

Funding